Loading…

DOP083 Recombinant subcutaneous human beta-Defensin 2 (hBD2) ameliorates experimental colitis in different in vivo models

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2017-02, Vol.11 (suppl_1), p.S75-S76
Main Authors:	Mailänder-Sánchez, D., Kjaerulf, S., Sidelmann Brinch, K., Andersen, B., Stange, E.F., Malek, N., Nordkild, P., Wehkamp, J.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!